MedTrace Logo

Dexamethasone in Total Knee and Total Hip Arthroplasty

NCT02760043 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2017-11-24

No results posted yet for this study

Summary

This study will evaluate if the addition of dexamethasone to a local infiltration analgesia mixture will improve functional outcomes following total hip and knee arthroplasty.

Conditions

Interventions

DRUG

Dexamethasone

8mg (2mL) of Dexamethasone added to standard LIA mixture

OTHER

0.9% NaCl Placebo

2mL of 0.9% NaCl placebo (saline) added to standard LIA mixture

DRUG

LIA Combination Mixture

150mL 2% Ropivacaine, 30mg Ketorolac and 0.6mg of Epinephrine

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02760043 on ClinicalTrials.gov